Synopsis of Social media discussions
The overall sentiment leans toward disagreement with the publication’s recommendations, with discussions highlighting fears of unnecessary biopsies and harm, as seen in comments referring to the risks associated with PSA testing, and skepticism about a mass screening approach. The tone suggests concern and critical analysis, with some users sharing links and referencing official guidelines to support their viewpoints.
Agreement
Low agreementMost comments reflect skepticism or disagreement with the recommendations, emphasizing potential harms and questioning the value of PSA screening.
Interest
Moderate level of interestThe discussions show moderate interest, with users engaging by referencing the publication and sharing links, indicating curiosity about the topic.
Engagement
Moderate level of engagementComments include personal opinions, citations of studies, and sharing opinions on the risks and benefits, demonstrating active engagement.
Impact
Neutral impactThe discussions seem to influence perceptions but do not appear to cause immediate widespread change or policy shifts, indicating a moderate impact.
Social Mentions
YouTube
2 Videos
1 Posts
13 Posts
2 Posts
Blogs
1 Articles
News
17 Articles
Metrics
Video Views
15,170
Total Likes
468
Extended Reach
334,839
Social Features
36
Timeline: Posts about article
Top Social Media Posts
Jose Mª Molero
Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https://t.co/MWiaifkabq
view full post
Hany Ragy
Wrong message!
Read this
https://t.co/X7UlWBM1HM https://t.co/n7dRcHlFq0
view full post
Hany Ragy
@Dr_Michel_Nabil Hello, the risk benefit is against mass screening by PSA, it harms more people than the small amount diagnosed , by leading many to unnecessary and dangerous biopsies , by creating fear in healthy men.
The paper :
https://t.co/X7UlWBM1HM
view full post
Hany Ragy
@Dr_Michel_Nabil Hello, you can read the paper here
https://t.co/X7UlWBM1HM
view full post
La chuleta de Osler
RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full post
Posts referencing the article
Impact of Finasteride on Blood Tests and Hormonal Levels in Men
This video discusses the necessary blood work when taking finasteride, highlighting its effects on serum hormones and implications for male pattern baldness treatment.
January 15, 2025
15,140 views
Understanding PSA Test and Prostate Cancer Screening Guidelines
Son tiles el PSA TR para el cancer de prostata. Today we discuss prostate cancer screening and bust common myths, referencing recent guidelines on early detection and testing recommendations.
October 29, 2025
30 views
-
Wrong message! Read this https://t.co/X7UlWBM1HM https://t.co/n7dRcHlFq0
view full postNovember 18, 2024
1
-
Adilson Boson, Jr
@AdilsonBoson (Twitter)@AlessandroLoio2 JAMA. 2018;319(18):1901-1913. doi:10.1001/jama.2018.3710 Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement: against PSA-based screening for prostate cancer in men 70 years and older; For 55-69y, decision should be individualized.
view full postNovember 8, 2023
-
Paco Camarelles
@pcamarelles (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 8, 2022
8
-
NoGracias
@nogracias_eu (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 7, 2022
8
-
Omid Hakami Hakami
@Omidhakami (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 6, 2022
8
-
Fernando Alonso
@Bolaredo (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 6, 2022
8
-
Ángel López Hernanz
@angelopezh (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 6, 2022
8
-
La chuleta de Osler
@chuletadeosler (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 6, 2022
8
-
Lola Carpio
@lola2cp (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 6, 2022
8
-
Jesús Palacio
@je_pala (Twitter)RT @jmolerog: Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https…
view full postAugust 5, 2022
8
-
Jose Mª Molero
@jmolerog (Twitter)Ni PAPPS de @semfyc https://t.co/clDTZN1gIu ni US Preventiva Services Task Force lo recomiendan https://t.co/PsBNq3nzti https://t.co/MWiaifkabq
view full postAugust 5, 2022
16
8
-
Hany Ragy
@Hragy (Twitter)@Dr_Michel_Nabil Hello, the risk benefit is against mass screening by PSA, it harms more people than the small amount diagnosed , by leading many to unnecessary and dangerous biopsies , by creating fear in healthy men. The paper : https://t.co/X7UlWBM1HM
view full postSeptember 20, 2021
-
Hany Ragy
@Hragy (Twitter)@Dr_Michel_Nabil Hello, you can read the paper here https://t.co/X7UlWBM1HM
view full postSeptember 20, 2021
-
Exámenes de detección del cáncer de próstata: ¿Debes someterte a ...
JAMA. 2018; doi:10.1001/jama.2018.3710. Wei JT, et al. Early detection of prostate cancer: AUA/SUO guideline part I: Prostate cancer screening. The Journal ...
view full postDecember 13, 2025
News
-
CESONCO200104-Tamizaje contra el cáncer | PPTX
Screening for ProstateCancer US Preventive Services Task Force Recommendation Statement JAMA. 2018;319(18):1901-1913. doi:10.1001/jama.2018.3710. 51 ...
view full postDecember 13, 2025
News
-
USPSTF勧告、前立腺がんPSA検診の非推奨を修正 Prostate-Specific ...
org/10.1001/jama.2018.3710）。一方、70歳以上の男性では非推奨が維持されている ... The Journal of the American Medical Association（JAMA）、Journal of ...
view full postDecember 13, 2025
News
-
Prostate cancer screening: Should you get screened? - Mayo Clinic
JAMA. 2018; doi:10.1001/jama.2018.3710. Wei JT, et al. Early detection of prostate cancer: AUA/SUO guideline part I: Prostate cancer screening. The Journal ...
view full postDecember 13, 2025
News
-
CES202001_CaProstata | PPTX
Screening for ProstateCancer US Preventive Services Task Force Recommendation Statement JAMA. 2018;319(18):1901-1913. doi:10.1001/jama.2018.3710. 7 ...
view full postDecember 13, 2025
News
-
Francesco Cremona - un Medico
... task force recommendation statement. JAMA. 2018;319(18): 1901–1913; doi:10.1001/jama.2018.3710.
view full postDecember 13, 2025
Facebook
-
Revolucionou o tratamento do cancro nas últimas décadas e as ...
JAMA. 2018. doi: 10.1001/jama.2018.3710. Braga I, Gonçalves-Monteiro S, Calisto R, et al. Real world retrospective study of early stage ...
view full postDecember 2, 2025
Instagram
-
Estima-se que 1,5 milhões de homens são diagnosticados com ...
ℹ️ Fontes: US Preventive Services Task Force et al. Screening for prostate cancer. JAMA. 2018. doi: 10.1001/jama.2018.3710. Braga I, Gonçalves- ...
view full postNovember 28, 2025
Instagram
-
前列腺癌筛查：您是否需要进行筛查？ - 妙佑医疗国际
JAMA. 2018; doi:10.1001/jama.2018.3710. Wei JT, et al. Early detection of prostate cancer: AUA/SUO guideline part I: Prostate cancer ...
view full postApril 23, 2025
News
-
فحوصات الكشف عن سرطان البروستاتا: هل يجب عليك إجراء الفحص ...
JAMA. 2018; doi:10.1001/jama.2018.3710. Wei JT, et al. Early detection of prostate cancer: AUA/SUO guideline part I: Prostate cancer ...
view full postApril 13, 2025
News
-
Updates in Cancer Prevention and Screening for 2025: A ...
JAMA. 2018;319(18):1901-1913. doi:10.1001/jama.2018.3710. US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Screening for Skin ...
view full postJanuary 12, 2025
News
-
Summary of Interests
JAMA. 2018 May 8;319(18):1901-13. doi: 10.1001/jama.2018.3710. PMID: 29801017. 283. Alsan M, Kammili N, Lakshmi J, Xing A, Khan A, Rani M ...
view full postMarch 29, 2024
News
-
The Clinical and Economic Benefits Associated With Novel Multi ...
JAMA Health Forum. 2022;3(5):e221229-e221229. doi: 10.1001 ... doi: 10.1001/jama.2018.3710; Use of decision models in the ...
view full postAugust 26, 2022
News
-
Examining Developments in Multicancer Early Detection: Highlights ...
JAMA. 2018;319(18):1901-1913. doi: 10.1001/jama.2018.3710. 9. US Preventive Services Task Force. Prostate cancer screening. Published May 8 ...
view full postDecember 3, 2021
News
-
Updated Screening Guidelines for 5 Cancer Types - Cancer ...
JAMA. 2018;319(18):1901-1913. doi:10.1001/jama.2018.3710; Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the ...
view full postAugust 10, 2021
News
-
Risk of prostate cancer in relatives of prostate cancer patients in ...
JAMA. 2018; 319(18):1901–13. https://doi.org/10.1001/jama.2018.3710 PMID: 29801017. 10. Brandt A, Bermejo JL, Sundquist J, Hemminki K. Age at ...
view full postJune 1, 2021
News
-
Risk of prostate cancer in relatives of prostate cancer patients in ...
JAMA. 2018;319(18):1901–13. doi: 10.1001/jama.2018.3710. pmid:29801017. 10. Brandt A, Bermejo JL, Sundquist J, Hemminki K. Age at diagnosis ...
view full postJune 1, 2021
News
-
Polygenic risk-tailored screening for prostate cancer: A benefit–harm ...
JAMA. 2018;319: 1901–1913. doi: 10.1001/jama.2018.3710. pmid:29801017. 2. Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL, Martin RM, et ...
view full postDecember 20, 2019
News
-
Polygenic risk-tailored screening for prostate cancer: A benefit–harm ...
JAMA. 2018; 319: 1901–1913. https://doi.org/10.1001/jama.2018.3710 PMID: 29801017. 2. Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL ...
view full postDecember 20, 2019
News
-
Men between 55 to 69 years allowed to use their discretion for PSA ...
For further reference log on to : doi:10.1001/jama.2018.3710 · Douglas K OwensJAMAprostate cancerprostate specific antigenPSAscreeningUS ...
view full postMay 11, 2018
News
-
Large clinical trials change experts' minds on prostate cancer ...
JAMA, 2018. DOI: 10.1001/jama.2018.3710 (About DOIs). Listing image: Getty | UniveralImagesGroup · Photo of Beth Mole · Beth Mole Senior Health ...
view full postMay 9, 2018
Blogs
Abstract Synopsis
- The USPSTF recommends individual decision-making about PSA screening for men aged 55-69 since it can reduce prostate cancer deaths but also carries risks like false positives and side effects from treatment such as incontinence and erectile dysfunction.
- Screening may prevent some cases of advanced prostate cancer, especially in high-risk groups like African American men and those with a family history, but it also leads to overdiagnosis and unnecessary treatment.
- Overall, the decision to screen should involve weighing the potential benefits of reducing mortality against the possible harms of false positives, overtreatment, and side effects, particularly considering age and risk factors.]
Hany Ragy
@Hragy (Twitter)